• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Chlorhexidine Lacer Mouthwash
    / Taro


    Active Ingredient

    Status in Israel
    OTC

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Oral Solution

    200 ml

    not in the basket chart

    Oral Solution

    500 ml

    not in the basket chart

    Dosage

    Adults: Thorough rinse wash of the mouth should be performed for about one minute with 15 ml twice daily. Spit out after use. In the dental surgery, the patient should be instructed to rinse the mouth for one minute prior to treatment.
    For the treatment of gingivitis, a course of about one month is advisable although some variation in response is to be expected. In the case of aphthous ulceration and oral candidal infections treatment should be continued for 48 hours after clinical resolution.
    For the treatment of dental stomatitis, the dentures should be cleansed and soaked in the mouthwash for fifteen minutes twice daily.
    Do not exceed the stated dose.
    Children and the Elderly: The normal adult dose is appropriate for elderly patients and children of 12 years and over.
    Children under 12 years of age should not use the product.
    Route of administration: Oromucosal use. This product is not intended to be swallowed.


    Indications

    Antibacterial solution for the disinfection of the mouth.
    As an aid to maintaining oral hygiene.
    As an aid in the treatment and prevention of gingivitis.
    Inhibition of formation of dental plaque.
    For use in aphtous ulceration and oral candidal infections (e.g. denture stomatitis and thrush).
    For use in a post-periodontal surgery or treatment regimen to promote gingival healing.  


    Contra-Indications

    Patients with known hypersensitivity to Chlorhexidine or to any of the excipients in the formulation.


    Special Precautions

    For oromucosal use only.
    The product is not intended for swallowing.
    Eyes and ears contact should be avoided.
    If the mouthwash comes in contact with the eyes, it should be washed  out promptly and thoroughly with water.
    In case of soreness, swelling or irritation of the mouth the use of the product should be discontinued.
    This  Mouthwash is incompatible with anionic agents which are usually present in conventional dentifrices.
    These should therefore be used before this  Mouthwash (rinsing the mouth between applications) or at a different time of day.
    In case of swelling, or breathing difficulty the product should be discontinued and medical help should be provided.
    Transient disturbances of taste sensation and a numbness, tingling or burning sensation of the tongue may occur on initial use of the mouthwash.
    These effects usually diminish with continued use.
    Discoloration of the teeth and tongue may occur.
    The stain is not permanent and can largely be prevented by reducing the consumption of dietary chromagens such as tea, coffee or red wine.
    In the case of dentures this can be prevented by cleaning with a conventional denture cleaner. In certain cases, professional treatment (scaling and polishing) may be required to remove the stain completely. Stained anterior tooth-coloured restorations with poor margins or rough surfaces which are not adequately cleaned by professional prophylaxis may require replacement.
    Similarly, where normal toothbrushing is not possible, for example with intermaxillary fixation, or with extensive orthodontic appliances, scaling and polishing may also be required once the underlying condition has been resolved.
    PEG-40 Hydrogenated Castor Oil may cause skin reactions.
    See prescribing information for full details.


    Side Effects

    Tongue coated, dry mouth, aguesia/dysguesia, glossodynia, oral paraesthesia/ hypoaesthesia.
    See prescribing information for full details.


    Drug interactions

    Chlorhexidine is incompatible with anionic agents.
    See prescribing information for full details.


    Pregnancy and Lactation

    There is no evidence of any adverse effects on the fetus arising from the use of chlorhexidine digluconate during pregnancy or on infants during lactation. Therefore, no special precautions are recommended.


    Overdose

    Overdose has not been reported.
    Accidental ingestion chlorhexidine taken orally is poorly absorbed. Systemic effects are unlikely even if large volumes are ingested. However, gastric lavage may be advisable using milk, raw egg, gelatin or mild soap. Employ supportive measures as appropriate.


    Important notes

    Shelf-life: after opening 21 days.
    Storage: Do not store above 25°C. Protect from light.


    Manufacturer
    Lacer S.A., Spain
    CLOSE